Synthetic DNA-encoded checkpoint inhibitor antibodies advance cancer immunotherapy - THE Politico Post
Wistar scientists and collaborators demonstrate for the first time that through engineering constructs, they can express DNA-encoded monoclonal antibodies (DMAbs) targeting CTLA-4, an important cancer checkpoint molecule that blocks anti-cancer immunity. Using a synthetic DNA [...]
[Source: politicopost.com] [ Comments ] [See why this is trending]
[Source: politicopost.com] [ Comments ] [See why this is trending]
Comments